+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Negative Pressure Wound Therapy Market - Industry Analysis and Market Forecast (2020 - 2025)

  • PDF Icon


  • 90 Pages
  • August 2020
  • Region: Europe
  • Mordor Intelligence
  • ID: 5176132
UP TO OFF until Mar 31st 2024
Negative pressure wound therapy is considered to be the most preferred choice of treatment, especially for deep acute wounds and persistent chronic wounds including leg ulcers. The topical use of NPWT has been widely studied in the literature over the past 20 years. Most clinical trials have shown the effectiveness of this therapy in the treatment of superficial wounds. Moreover, the localized use of NPWT in infected wounds offers advantages, such as wound drainage, angiogenesis stimulation, proteinase excretion, and decreased local and systemic bacterial load.

Therefore the increasing prevalence of chronic wounds and diabetic ulcers in the region and technological advancements in the NPWT devices are fueling the market growth. However the high cost of the treatment and complications associated with the NPWT devices are major restraints for the growth of the market in the region.

Key Market Trends

Diabetic Foot Ulcers are Expected to Witness Rapid Growth in the Market Studied

Diabetic Foot Ulcers (DFU) is one of the most common complications associated with Diabetes and is posing a huge burden on several countries across the European region. The diabetic foot ulcer occurs in approximately 15 percent of patients with diabetes, and therefore the increasing diabetic population in the region is contributing to the dominant share of the segment. According to the International Diabetes Federation, 2019, there are about 59 million people with diabetes in the European Region or about 10.3% of men and 9.6% of women aged 20-79 years. The prevalence of diabetes is increasing among all ages in the European Region, mostly due to increases in overweight and obesity, unhealthy diet, and physical inactivity. Thus owing to the increasing prevalence of diabetes and diabetic foot ulcer, the market is expected to grow over the forecast period.

Competitive Landscape

The Europe Negative Pressure Wound Therapy Market is moderately competetive with several major players. Some of the strategies implemented include agreements, collaborative models, business expansion, and product developments. Some of the major players are Molnlycke Health Care, ConvaTec Inc., Cardinal Health, Inc., Smith & Nephew plc, 3M.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Number of Accidents and Traumatic Events
4.2.2 Rising Chronic Wounds Such as Diabetic Foot Ulcers
4.2.3 Technological Advancements in the NPWT Devices
4.3 Market Restraints
4.3.1 High Cost of Device and Treatment
4.3.2 Complications Associated With NPWT Device
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Product
5.1.1 Re-Usable Device
5.1.2 Single-Use Device
5.2 By Wound Type
5.2.1 Diabetic Foot Ulcer
5.2.2 Pressure Ulcer
5.2.3 Venous Leg Ulcer
5.2.4 Burn Wounds
5.2.5 Others
5.3 By End-User
5.3.1 Hospital
5.3.2 Homecare
5.3.3 Others
5.4 Geography
5.4.1 Europe Germany United Kingdom France Italy Spain Rest of Europe
6.1 Company Profiles
6.1.1 Molnlycke Health Care
6.1.2 ConvaTec Inc.
6.1.3 Cardinal Health, Inc.
6.1.4 Smith & Nephew plc
6.1.5 3M (Acelity L.P. Inc.)
6.1.6 Talley Group Limited
6.1.7 Devon Medical, Inc
6.1.8 Medela AG
6.1.9 DeRoyal Industries, Inc.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Molnlycke Health Care
  • ConvaTec Inc.
  • Cardinal Health, Inc.
  • Smith & Nephew plc
  • 3M (Acelity L.P. Inc.)
  • Talley Group Limited
  • Devon Medical, Inc
  • Medela AG
  • DeRoyal Industries, Inc.